CAM
ACIU icon

Connacht Asset Management’s AC Immune ACIU Stock Holding History

Connacht Asset Management’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-44,026
Closed -$335K – 112
2021
Q1 		$335K Buy
+44,026
New +$314K 0.07% 110

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

Connacht Asset Management's ACIU Position: Q2 2021 in Review

Connacht Asset Management sold out of AC Immune (ACIU) in Q2 2021, closing a stake of 44,026 shares — an estimated $335K sold.

Connacht Asset Management first reported a position in ACIU in Q1 2021 and held it in 1 quarter. The position peaked at $335K in Q1 2021. 57 funds tracked by Wall St. Rank hold ACIU as of Q2 2021.

  • Connacht Asset Management reported no remaining AC Immune position as of Q2 2021 after selling out during the quarter.
  • Connacht Asset Management sold 44,026 AC Immune shares in Q2 2021, an estimated $335K.
  • Connacht Asset Management first reported a position in AC Immune in Q1 2021 and held it in 1 quarter.
  • Connacht Asset Management's AC Immune position peaked at $335K in Q1 2021.
  • 57 funds tracked by Wall St. Rank held AC Immune as of Q2 2021.

Based on Connacht Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.